Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Generation of C5a in the absence of C3: a new complement activation pathway

Abstract

Complement-mediated tissue injury in humans occurs upon deposition of immune complexes, such as in autoimmune diseases and acute respiratory distress syndrome. Acute lung inflammatory injury in wild-type and C3−/− mice after deposition of IgG immune complexes was of equivalent intensity and was C5a dependent, but injury was greatly attenuated in Hc−/− mice (Hc encodes C5). Injury in lungs of C3−/− mice and C5a levels in bronchoalveolar lavage (BAL) fluids from these mice were greatly reduced in the presence of antithrombin III (ATIII) or hirudin but were not reduced in similarly treated C3+/+ mice. Plasma from C3−/− mice contained threefold higher levels of thrombin activity compared to plasma from C3+/+ mice. There were higher levels of F2 mRNA (encoding prothrombin) as well as prothrombin and thrombin protein in liver of C3−/− mice compared to C3+/+ mice. A potent solid-phase C5 convertase was generated using plasma from either C3+/+ or C3−/− mice. Human C5 incubated with thrombin generated C5a that was biologically active. These data suggest that, in the genetic absence of C3, thrombin substitutes for the C3-dependent C5 convertase. This linkage between the complement and coagulation pathways may represent a new pathway of complement activation.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy article

Get time limited or full article access on ReadCube.

$32.00

All prices are NET prices.

Figure 1: Immune complex–induced injury in C5 and C3 wild-type and knockout mice.
Figure 2: Lung injury in C3+/+ and C3−/− mice and protective effects of C5a-specific antibody (anti-C5a).
Figure 3: Generation of C5a activity in C3+/+ and C3−/− plasma and formation of a solid-phase C5 convertase.
Figure 4: Evidence for thrombin as a C5 convertase.

References

  1. Abbas, A.K. Disease of immunity. in Robbins Pathologic Basis of Disease 6th edn. (eds. Cotran, R., Kumar, V. & Collins, T.) Ch 6, 188–260 (W.B. Saunders & Co., Philadelphia, 1999).

    Google Scholar 

  2. Kohl, J. & Gessner, J.E. On the role of complement and Fcγ-receptors in the Arthus reaction. Mol. Immunol. 36, 893–903 (1999).

    Article  CAS  Google Scholar 

  3. Clynes, R. et al. Modulation of immune complex-induced inflammation in vivo by the coordinate expression of activation and inhibitory Fc receptors. J. Exp. Med. 189, 179–185 (1999).

    Article  CAS  Google Scholar 

  4. Baumann, U. et al. A codominant role of FcγRI/III and C5aR in the reverse Arthus reaction. J. Immunol. 164, 1065–1070 (2000).

    Article  CAS  Google Scholar 

  5. Hopken, U.E., Lu, B., Gerard, N.P. & Gerard, C. Impaired inflammatory responses in the reverse Arthus reaction through genetic deletion of the C5aR. J. Exp. Med. 186, 749–756 (1997).

    Article  CAS  Google Scholar 

  6. Wang, Y. et al. Amelioration of lupus-like autoimmune disease in NZB/WF1 mice after treatment with a blocking monoclonal antibody specific for complement component C5. Proc. Natl. Acad. Sci. USA 93, 8563–8568 (1996).

    Article  CAS  Google Scholar 

  7. Strachan, A.J., Shiels, I.A., Reid, R.C., Fairlie, D.P. & Taylor, S.M. Inhibition of immune-complex mediated dermal inflammation in rats following either oral or topical administration of a small molecule C5a receptor antagonist. Br. J. Pharmacol. 134, 1778–1786 (2001).

    Article  CAS  Google Scholar 

  8. Heller, T. et al. Selection of a C5a receptor antagonist from phage libraries attenuating the inflammatory response in immune complex disease and ischemia/reperfusion injury. J. Immunol. 163, 985–994 (1999).

    CAS  PubMed  Google Scholar 

  9. Baumann, U. et al. Distinct tissue site-specific requirements of mast cells and complement components C3/C5a receptor in IgG immune complex-induced injury of skin and lung. J. Immunol. 167, 1022–1027 (2001).

    Article  CAS  Google Scholar 

  10. Ames, R.S. et al. Identification of a selective nonpeptide antagonist of the anaphylatoxin C3a receptor that demonstrates antiinflammatory activity in animal models. J. Immunol. 166, 6341–6348 (2001).

    Article  CAS  Google Scholar 

  11. Humbles, A.A. et al. A role for the C3a anaphylatoxin receptor in the effector phase of asthma. Nature 406, 998–1001 (2000).

    Article  CAS  Google Scholar 

  12. Sylvestre, D. et al. Immunoglobulin G-mediated inflammatory responses develop normally in complement-deficient mice. J. Exp. Med. 184, 2385–2392 (1996).

    Article  CAS  Google Scholar 

  13. Weiser, M. et al. Reperfusion injury of ischemic skeletal muscle is mediated by natural antibody and complement. J. Exp. Med. 183, 2343–2348 (1996).

    Article  CAS  Google Scholar 

  14. Hugli, T.E. Complement factors and inflammation: effects of α-thrombin on components C3 and C5. in Chemistry and Biology of Thrombin (eds. Lundblad, R.L., Fenton, J.W. & Mann, K.G.) 345–360 (Ann Arbor Science Publishers, Inc. Ann Arbor, Michigan, 1977).

  15. Polley, M.J. & Nachman, R. The human complement system in thrombin-mediated platelet function. J. Exp. Med. 147, 1713–1726 (1978).

    Article  CAS  Google Scholar 

  16. Wetsel, R.A. & Kolb, W.P. Expression of C5a-like biological activities by the fifth component of human complement (C5) upon limited digestion with noncomplement enzymes without release of polypeptide fragments. J. Exp. Med. 157, 2029–2048 (1983).

    Article  CAS  Google Scholar 

  17. Ward, P.A. & Hill, J.H. C5 chemotactic fragments produced by an enzyme in lysosomal granules of neutrophils. J. Immunol. 104, 535–543 (1970).

    CAS  PubMed  Google Scholar 

  18. HuberLang, M. et al. Generation of C5a by phagocytic cells. Am. J. Pathol. 161, 1849–1859 (2002).

    Article  CAS  Google Scholar 

  19. Rawal, N. & Pangburn, M.K. Formation of high affinity C5 convertase of the classical pathway of complement. J. Biol. Chem. 278, 38476–38483 (2003).

    Article  CAS  Google Scholar 

  20. Mulligan, M.S. et al. Requirement and role of C5a in acute lung injury in rats. J. Clin. Invest. 98, 503–512 (1996).

    Article  CAS  Google Scholar 

  21. Larsen, G.L., Mitchell, B.C. & Henson, P.M. The pulmonary response of C5 sufficient and deficient mice to immune complexes. Am. Rev. Respir. Dis. 123, 434–439 (1981).

    CAS  PubMed  Google Scholar 

  22. Larsen, G.L., Mitchell, B.C., Harper, T.B. & Henson, P.M. The pulmonary response of C5 sufficient and deficient mice to Pseudomonas aeruginosa. Am. Rev. Respir. Dis. 126, 306–311 (1982).

    CAS  PubMed  Google Scholar 

  23. Barton, P.A. & Warren, J.S. Complement component C5 modulates the systemic tumor necrosis factor response in murine endotoxin shock. Infect. Immun. 61, 1474–1481 (1993).

    CAS  PubMed  PubMed Central  Google Scholar 

  24. Kyriakides, C. et al. Membrane attack complex of complement and neutrophils mediate the injury of acid aspiration. J. Appl. Physiol. 87, 2357–2361 (1999).

    Article  CAS  Google Scholar 

  25. Czermak, B.J. et al. In vitro and in vivo dependency of chemokine generation on C5a and TNFα. J. Immunol. 162, 2321–2325 (1999).

    CAS  PubMed  Google Scholar 

  26. Drouin, S.M., Corry, D.B., Hollman, T.J., Kildsgaard, J. & Wetsel, R.A. Absence of the complement anaphylatoxin C3a receptor suppresses Th2 effector functions in a murine model of pulmonary allergy. J. Immunol. 169, 5926–5933 (2002).

    Article  CAS  Google Scholar 

  27. Wills-Karp, M. & Ewart, S.L. Time to draw breath: asthma-susceptibility genes are identified. Nat. Rev. Genet. 5, 376–387 (2004).

    Article  CAS  Google Scholar 

  28. Walters, D.M., Breysse, P.N., Schofield, B. & Wills-Karp, M. Complement factor 3 mediates particulate matter-induced airway hyperresponsiveness. Am. J. Respir. Cell Mol. Biol. 27, 413–418 (2002).

    Article  CAS  Google Scholar 

  29. Circolo, A. et al. Genetic disruption of the murine complement C3 promoter region generates deficient mice with extra hepatic expression of C3 mRNA. Immunopharmacology 42, 135–149 (1999).

    Article  CAS  Google Scholar 

  30. Guo, R.F. & Ward, P.A. Role of C5a in inflammatory responses. Annu. Rev. Immunol. 23, 821–852 (2005).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This work was supported by US National Institutes of Health grants GM-29507, HL-31963 (to P.A.W.), GM-069438 (to J.G.Y.), DK-59422, AI-30040 and GM-069736 (to J.D.L.) and Deutsche Forschungsgemeinschaft grant HU823/2-2 (to M.H.-L.). We thank B. Schumann for secretarial assistance in preparation of the manuscript and R. Kunkel for assistance in preparing illustrations. We thank S. Albers for laboratory assistance. We thank A. Schmaier for suggestions regarding the prothrombin/thrombin studies and M. Carroll for supplying a second C3−/− strain of mice.

Author information

Authors and Affiliations

Authors

Contributions

M.H.-L., J.V.S., F.S.Z., S.M.D., R.L.W., M.A.F., D.R., L.M.H., R.A.W., S.R.M., T.A.N., J.G.Y. and P.A.W. contributed to animal models. J.V.S., F.S.Z., J.D.L. and T.A.N. contributed to ATIII and hirudin experiments. J.D.L. and F.G. contributed to thrombin experiments.

Corresponding author

Correspondence to Peter A Ward.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Huber-Lang, M., Sarma, J., Zetoune, F. et al. Generation of C5a in the absence of C3: a new complement activation pathway. Nat Med 12, 682–687 (2006). https://doi.org/10.1038/nm1419

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm1419

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing